Overcoming inefficiencies to improve access to cell and gene therapy
Drug Discovery World
MARCH 13, 2023
Between the 24 therapies already approved by the FDA 1 and a marked increase in clinical trials, widespread accessibility to precision medicine feels within reach. The individual successes within the CGT market are impressive, but this therapeutic class remains unattainable to the vast majority of the world. August 2020. April 4, 2022.
52 
Let's personalize your content